Mechanisms of axon-glial injury of the optic nerve

Eye

Volumn 18, Issue 11, 2004, Pages 1182-1187

  Compston, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Axonal injury; Demyelination; Growth factors; Inflammation; Multiple sclerosis; Optic nerve; Remyelination

Indexed keywords

CORTICOSTEROID; GROWTH FACTOR; METHYLPREDNISOLONE;

ARTICLE; AXONAL INJURY; CELL DAMAGE; CELL DEATH; CELL MEMBRANE; CELL PROTECTION; CLINICAL TRIAL; DEMYELINATION; DISEASE COURSE; ENCEPHALITIS; GLIA; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE DISEASE; PATHOGENESIS; REMYELINIZATION; TISSUE INJURY;

EID: 9944253740     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701561     Document Type: Article

References (40)

1. Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR et al. Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology 2000; 54: 1859-1861.
2. Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992; 115: 979-989.
3. Riordan-Eva P, Sanders MD, Govan GG, Sweency MG, Da Costa J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118: 319-337.
4. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's synsrome). Neurology 1999; 53: 1107-1114.
5. Lucchinetti CF, Mandler R, McGavern D, Bruck W, Gleich G, Ransohoff RM et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2000; 125 1450-1461.
6. Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999; 46: 878-886.
7. Kalman B, Mandler RN. Studies of mitochondrial DNA in Devic's disease revealed no pathogenic mutations, but polymorphisms also found in association with multiple sclerosis. Ann Neurol 2002; 51: 661-662.
8. Reynier P, Penisson-Besnier I, Moreau C, Savagner F, Vielle B, Emile J et al. mtDNA haplotyping J: a contributing factor of optic neuritis. Eur J Hum Genet 1999; 7: 404-406.
9. Brex PA, Gomez-Anson B, Parker GJ, Molyneux PD, Miszkiel KA, Barker GJ et al. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J Neurol Sci 1999; 66: 16-22.
10. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-2450.
11. Hickman SJ, Brex PA, Brierley CMH, Silver NC, Barker GJ, Scolding NJ et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat saturated short echo fast FLAIR sequence. Neuroradiology 2001; 43: 123-128.
12. Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: a 2 year visual evoked potential and psychophysical serial study. Brain 2001; 124: 468-479.
13. Moreau T, Coles A, Wing M, Isaacs J, Hale G, Waldmann II, Compston A. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996; 119: 225-237.
14. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997; 120: 2149-2157.
15. Brinkmeier H, Aulkemeyer P, Wollinsky KH, Rudel R. An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nature Medicine 2000; 6: 808-811.
16. Smith KJ, Kapoor R, Hall SM, Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001; 49: 470-476.
17. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-399.
18. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Eng J Med 1998; 338: 278-285.
19. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995; 118: 1583-1592.
20. Simon JH, Jacobs L, Kinkel RP. Transcallosal bands: a sign of neuronal tract degeneration in early MS? Neurology 2001; 57: 1888-1890.
21. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002; 125: 2202-2212.
22. Nicholas RS, Compston A, Brown DR. Inhibition of tumour necrosis factor-alpha (TNFalpha)-induced NF-kappaB p52 converts the metabolic effects of microglial-derived TNFalpha on mouse cerebellar neurones to neurotoxicity. J Neurochem 2001; 76: 1431-1438.
23. Golde S, Chandran S, Brown GC, Compston A. Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. J Neurochem 2002; 82 269-282.
24. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 1997; 49: 1404-1413.
25. Beck RW, Cleary PA, Anderson Jr MM, Keltner JL, Shults WT, Kaufman DI et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis The Optic Neuritis Study Group. N Eng J Med 1992; 326: 581-588.
26. Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 2001; 57: 1239-1247.
27. Mathis C, Denisenko-Nehrbass N, Girault JA, Borrelli E. Essential role of oligodendrocytes in the formation and maintenance of central nervous system nodal regions. Development 2001; 128: 4881-4890.
28. Kaplan MR, Cho MH, Ullian EM, Isom LL, Levinson SR, Barres BA et al. Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron 2001; 30: 105-119.
29. Boiko T, Rasband MN, Levinson SR, Caldwell JII, Mandel G, Trimmer JS et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 2001; 30: 91-104.
30. England JD, Gamboni F, Levinson SR, Finger TE. Changed distribution of sodium channels along demyelinated axons. Proc Nat Acad Sci USA 1990; 87: 6777-6780.
31. Werring DJ, Bullmore ET, Toosy AT, Miller DII, Barker GJ, MacManus DG et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2000; 68: 441-449.
32. Coles AJ, Wing M, Molyneux P, Paolillo A, Davie CM, Hale G et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999; 46: 296-304.
33. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Eng J Med 2000; 343: 1430-1438.
34. Wilkins A, Chandran S, Compston A. A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 2001; 36: 48-57.
35. Wilkins A, Majed H, Layfield R, Compston A, Chandran S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 2003; 23: 4967-4974.
36. Barnett SC, Alexander CL, Iwashita Y, Gilson JM, Crowther J, Clark L et al. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 2000; 123: 1581-1588.
37. Kohama I, Lankford KL, Preiningerova J, White FA, Vollmer TL, Koesis JD et al. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 2001; 21: 944-950.
38. Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998; 121: 2221-2228.
39. Wolswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002; 125: 338-349.
40. Pluchino, S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688-694.